Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies

Total Page:16

File Type:pdf, Size:1020Kb

Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies REVIEW published: 05 June 2020 doi: 10.3389/fbioe.2020.00550 Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies José Carlos Andrade 1†, Diana Almeida 2†, Melany Domingos 2, Catarina Leal Seabra 2‡, Daniela Machado 2, Ana Cristina Freitas 2* and Ana Maria Gomes 2 1 CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra, Portugal, 2 CBQF - Centro de Biotecnologia e Química Fina - Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Porto, Portugal Edited by: Eduardo Jacob-Lopes, Federal University of Santa In the last years several human commensals have emerged from the gut microbiota Maria, Brazil studies as potential probiotics or therapeutic agents. Strains of human gut inhabitants Reviewed by: Julio Plaza-Diaz, such as Akkermansia, Bacteroides, or Faecalibacterium have shown several interesting University of Granada, Spain bioactivities and are thus currently being considered as food supplements or as John MacSharry, live biotherapeutics, as is already the case with other human commensals such as University College Cork, Ireland bifidobacteria. The large-scale use of these bacteria will pose many challenges and *Correspondence: Ana Cristina Freitas drawbacks mainly because they are quite sensitive to oxygen and/or very difficult [email protected] to cultivate. This review highlights the properties of some of the most promising †These authors have contributed human commensals bacteria and summarizes the most up-to-date knowledge on their equally to this work and share first potential health effects. A comprehensive outlook on the potential strategies currently authorship employed and/or available to produce, stabilize, and deliver these microorganisms is ‡Present address: Catarina Leal Seabra, also presented. LAQV, REQUIMTE, Departamento de Keywords: probiotics, gut commensals, live biotherapeutics, health, gut microbiota, production, storage, delivery Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal INTRODUCTION Specialty section: This article was submitted to In the last years the knowledge about the human microbiota and its role in health and disease Bioprocess Engineering, has advanced considerably. This advance has revived the interest on the use of naturally occurring a section of the journal bacteria from the human gut as therapeutic agents or as probiotics. Lactobacilli and bifidobacteria Frontiers in Bioengineering and have already a tradition of use in dietary or pharmaceutical forms and technologically robust strains Biotechnology have been isolated and are produced industrially. However, the human gut microbiota studies have Received: 23 March 2020 highlighted other species of commensals which are consistently under-represented in different Accepted: 07 May 2020 disease conditions. Commensal bacteria such as Akkermansia and Faecalibacterium have been Published: 05 June 2020 shown to exert relevant bioactivities, mainly in cell and animal models, and may be considered next- Citation: generation probiotics or live therapeutic products (O’Toole et al., 2017). While several important Andrade JC, Almeida D, Domingos M, aspects such as effectiveness, safety, physiological, genomic, and metabolomics characteristics Seabra CL, Machado D, Freitas AC still need to be completely understood, before a practical application can be put in place, other and Gomes AM (2020) Commensal overlooked aspects such as the production, storage stability, and delivery must also be investigated Obligate Anaerobic Bacteria and Health: Production, Storage, and (Jimenez et al., 2019). The latter aspects are extremely important to be explored as the commensal Delivery Strategies. microorganisms are usually strict anaerobes posing immediate challenges associated therewith. Front. Bioeng. Biotechnol. 8:550. In this review we summarize the current knowledge on the different strategies to produce, doi: 10.3389/fbioe.2020.00550 stabilize, and deliver anaerobic commensals with special emphasis on the associated impact on Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 1 June 2020 | Volume 8 | Article 550 Andrade et al. Commensal Obligate Anaerobic Bacteria and Health stability and biological activity. Some of the most promising defined as “dysbiosis,” which is a disruption in the mutually human commensals are presented and their potential health beneficial relationship between a host and its microbiota leading effects are discussed. to the manifestation or progress of a specific disease (Figure 1) (Singh et al., 2016). This instability is usually not able to be attributed to a HUMAN GUT MICROBIOTA, DYSBIOSIS single strain and is characterized mainly by the restriction of AND THE NEED FOR PROBIOTICS bacterial diversity, with a decline in beneficial bacterial strains abundance and a parallel increase of pathogenic bacteria and Humans are a complex organization of bacterial and human this transition from the healthy state to dysbiosis involves stimuli cells that make up cellular communities, tissues, and functional such as diet, host genetics, infection, or inflammation (Figure 1) organs. This elaborate organism formed by human beings and the (Levy et al., 2017). Clinically, dysbiosis has been implicated inhabitant microbiota is defined as holobiont (Postler and Ghosh, in pathogenesis of several intra and extra-intestinal diseases, 2017; van de Guchte et al., 2018). These bacterial communities including inflammatory bowel disease, allergy, asthma, metabolic residing at various ecological niches are an integrated part of syndrome, cardiovascular disease, and obesity (Carding et al., our biological system, in particular the gastrointestinal tract. 2015). Indeed, healthier dietary patterns, such as the increased The gut microbiome is a dynamic and balanced assembly of consumption of fibers, fermented foods and vegetables and microorganisms and the resultant products of their collective reduced consumption of saturated fats, have been linked with genetic and metabolic materials. They play an array of biological higher diversity and the manipulation of such parameter leads functions ranging from controlling gut-immune system axis, to compositional and functional shifts in intestinal microbiota, providing several key metabolites and maintaining an optimal ultimately correlating with diverse health outcomes (Wu et al., digestive system (Cani, 2018). With the advent of metagenomic 2011; Dao et al., 2016b). This being said, compliance to technologies, society is acknowledging the extreme influence such dietary recommendations by the general population is these microorganisms have on human health and disease known to be suboptimal (Krebs-Smith et al., 2010), and prevention, and the disturbance of their composition has been for this reason the introduction of bioactive agents, such as implicated, over the years, in an assortment of pathologies (Neef probiotic bacteria, is deemed as a promising approach to and Sanz, 2013). Indeed, to properly perform its functions, the reestablish the gut compositional harmony (Gagliardi et al., gut microbiota community must reveal a diverse, balanced and 2018). Historically, the concept of probiotic was firstly put stable composition, just like a perfectly in-tune orchestra, a into a scientific framework by the work of Russian Nobel healthy state defined as “eubiosis” (Figure 1)(Iebba et al., 2016). laureate Elie Metchnikoff at the Pasteur Institute in Paris Unfortunately, this intricate bionetwork can be disturbed, a state at the beginning of the twentieth century. Based on the FIGURE 1 | Graphical summary of probiotic impact in gut epithelium of host. SCFAs - Short chain fatty acids; GPCR - G-protein coupled receptors. Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 2 June 2020 | Volume 8 | Article 550 Andrade et al. Commensal Obligate Anaerobic Bacteria and Health hypothesis that regular consumption of fermented dairy products functionality is in effect another tool to further provide health with lactic acid bacteria (LAB) was associated with enhanced benefits, apart from those delivered by the ingested nutrients health and longevity in elderly Bulgarian people, Metchnikoff (Douillard and de Vos, 2019). demonstrated that the consumption of high viable cell numbers of beneficial lactobacilli via fermented milks prevented the Conventional Probiotics: the Current growth of negative proteolytic bacteria by lowering intestinal pH Health Heroes and consequently bringing benefits to host health (Metchnikoff, Over the past decades, probiotic strains have been isolated 1907). Thenceforth, the designation probiotic has been related from many sources, including human origin commensal to beneficial bacteria for the host health, although its definition microorganisms, derived from gut; and non-human origin has been modified over time (Gomes et al., 2017). Presently, resulting from dairy and non-dairy food and beverage the most well-accepted scientific definition of probiotic is fermentation, fresh fruits and vegetables among others “live microorganisms that, when administered in adequate (Sornplang and Piyadeatsoontorn, 2016). Despite the wide amounts, confer a health benefit on the host.” Such definition array of sources, the strains considered probiotic and used was proposed by the International Scientific Association for for commercial applications belong mainly to Lactobacillus Probiotics and Prebiotics (Hill et al., 2014) which maintained and Bifidobacterium genera and
Recommended publications
  • Macellibacteroides Fermentans Gen. Nov., Sp. Nov., a Member of the Family Porphyromonadaceae Isolated from an Upflow Anaerobic Filter Treating Abattoir Wastewaters
    International Journal of Systematic and Evolutionary Microbiology (2012), 62, 2522–2527 DOI 10.1099/ijs.0.032508-0 Macellibacteroides fermentans gen. nov., sp. nov., a member of the family Porphyromonadaceae isolated from an upflow anaerobic filter treating abattoir wastewaters Linda Jabari,1,2 Hana Gannoun,2 Jean-Luc Cayol,1 Abdeljabbar Hedi,1 Mitsuo Sakamoto,3 Enevold Falsen,4 Moriya Ohkuma,3 Moktar Hamdi,2 Guy Fauque,1 Bernard Ollivier1 and Marie-Laure Fardeau1 Correspondence 1Aix-Marseille Universite´ du Sud Toulon-Var, CNRS/INSU, IRD, MIO, UM 110, Case 925, Marie-Laure Fardeau 163 Avenue de Luminy, 13288 Marseille Cedex 9, France [email protected] 2Laboratoire d’Ecologie et de Technologie Microbienne, Institut National des Sciences Applique´es et de Technologie, Centre Urbain Nord, BP 676, 1080 Tunis Cedex, Tunisia 3Microbe Division/Japan Collection of Microorganisms, RIKEN BioResource Center 2-1 Hirosawa, Wako, Saitama 351-0198, Japan 4CCUG, Culture Collection, Department of Clinical Bacteriology, University of Go¨teborg, 41346 Go¨teborg, Sweden A novel obligately anaerobic, non-spore-forming, rod-shaped mesophilic bacterium, which stained Gram-positive but showed the typical cell wall structure of Gram-negative bacteria, was isolated from an upflow anaerobic filter treating abattoir wastewaters in Tunisia. The strain, designated LIND7HT, grew at 20–45 6C (optimum 35–40 6C) and at pH 5.0–8.5 (optimum pH 6.5–7.5). It did not require NaCl for growth, but was able to grow in the presence of up to 2 % NaCl. Sulfate, thiosulfate, elemental sulfur, sulfite, nitrate and nitrite were not used as terminal electron acceptors.
    [Show full text]
  • Description of Gabonibacter Massiliensis Gen. Nov., Sp. Nov., a New Member of the Family Porphyromonadaceae Isolated from the Human Gut Microbiota
    Curr Microbiol DOI 10.1007/s00284-016-1137-2 Description of Gabonibacter massiliensis gen. nov., sp. nov., a New Member of the Family Porphyromonadaceae Isolated from the Human Gut Microbiota 1,2 1 3,4 Gae¨l Mourembou • Jaishriram Rathored • Jean Bernard Lekana-Douki • 5 1 1 Ange´lique Ndjoyi-Mbiguino • Saber Khelaifia • Catherine Robert • 1 1,6 1 Nicholas Armstrong • Didier Raoult • Pierre-Edouard Fournier Received: 9 June 2016 / Accepted: 8 September 2016 Ó Springer Science+Business Media New York 2016 Abstract The identification of human-associated bacteria Gabonibacter gen. nov. and the new species G. mas- is very important to control infectious diseases. In recent siliensis gen. nov., sp. nov. years, we diversified culture conditions in a strategy named culturomics, and isolated more than 100 new bacterial Keywords Gabonibacter massiliensis Á Taxonogenomics Á species and/or genera. Using this strategy, strain GM7, a Culturomics Á Gabon Á Gut microbiota strictly anaerobic gram-negative bacterium was recently isolated from a stool specimen of a healthy Gabonese Abbreviations patient. It is a motile coccobacillus without catalase and CSUR Collection de Souches de l’Unite´ des oxidase activities. The genome of Gabonibacter mas- Rickettsies siliensis is 3,397,022 bp long with 2880 ORFs and a G?C DSM Deutsche Sammlung von content of 42.09 %. Of the predicted genes, 2,819 are Mikroorganismen protein-coding genes, and 61 are RNAs. Strain GM7 differs MALDI-TOF Matrix-assisted laser desorption/ from the closest genera within the family Porphyromon- MS ionization time-of-flight mass adaceae both genotypically and in shape and motility.
    [Show full text]
  • W O 2017/079450 Al 11 May 2017 (11.05.2017) W IPOI PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2017/079450 Al 11 May 2017 (11.05.2017) W IPOI PCT (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K35/741 (2015.01) A61K 35/744 (2015.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, A61K 35/745 (2015.01) A61K35/74 (2015.01) DO, DZ, EC, EE, EG, ES, Fl, GB, GD, GE, GH, GM, GT, C12N1/20 (2006.01) A61K 9/48 (2006.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, A61K 45/06 (2006.01) KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (21) International Application Number: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, PCT/US2016/060353 SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, (22) International Filing Date: TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, 3 November 2016 (03.11.2016) ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated,for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, (30) Priority Data: TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, 62/250,277 3 November 2015 (03.11.2015) US TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, Fl, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, (71) Applicants: THE BRIGHAM AND WOMEN'S HOS- LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, PITAL [US/US]; 75 Francis Street, Boston, Massachusetts SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, 02115 (US).
    [Show full text]
  • Downloaded from the VFDB Data- Base (Virulence Factors Database) Containing Nucleotide Sample Collection and Metagenomic Sequencing Sequences of 2585 Genes [53]
    Dubinkina et al. Microbiome (2017) 5:141 DOI 10.1186/s40168-017-0359-2 RESEARCH Open Access Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease Veronika B. Dubinkina1,2,3,4, Alexander V. Tyakht2,5*, Vera Y. Odintsova2, Konstantin S. Yarygin1,2, Boris A. Kovarsky2, Alexander V. Pavlenko1,2, Dmitry S. Ischenko1,2, Anna S. Popenko2, Dmitry G. Alexeev1,2, Anastasiya Y. Taraskina6, Regina F. Nasyrova6, Evgeny M. Krupitsky6, Nino V. Shalikiani7, Igor G. Bakulin7, Petr L. Shcherbakov7, Lyubov O. Skorodumova2, Andrei K. Larin2, Elena S. Kostryukova1,2, Rustam A. Abdulkhakov8, Sayar R. Abdulkhakov8,9, Sergey Y. Malanin9, Ruzilya K. Ismagilova9, Tatiana V. Grigoryeva9, Elena N. Ilina2 and Vadim M. Govorun1,2 Abstract Background: Alcohol abuse has deleterious effects on human health by disrupting the functions of many organs and systems. Gut microbiota has been implicated in the pathogenesis of alcohol-related liver diseases, with its composition manifesting expressed dysbiosis in patients suffering from alcoholic dependence. Due to its inherent plasticity, gut microbiota is an important target for prevention and treatment of these diseases. Identification of the impact of alcohol abuse with associated psychiatric symptoms on the gut community structure is confounded by the liver dysfunction. In order to differentiate the effects of these two factors, we conducted a comparative “shotgun” metagenomic survey of 99 patients with the alcohol dependence syndrome represented by two cohorts—with and without liver cirrhosis. The taxonomic and functional composition of the gut microbiota was subjected to a multifactor analysis including comparison with the external control group. Results: Alcoholic dependence and liver cirrhosis were associated with profound shifts in gut community structures and metabolic potential across the patients.
    [Show full text]
  • Parabacteroides Distasonis
    University of Groningen Parabacteroides distasonis Ezeji, Jessica C.; Sarikonda, Daven K.; Hopperton, Austin; Erkkila, Hailey L.; Cohen, Daniel E.; Martinez, Sandra P.; Cominelli, Fabio; Kuwahara, Tomomi; Dichosa, Armand E. K.; Good, Caryn E. Published in: Gut Microbes DOI: 10.1080/19490976.2021.1922241 IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2021 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Ezeji, J. C., Sarikonda, D. K., Hopperton, A., Erkkila, H. L., Cohen, D. E., Martinez, S. P., Cominelli, F., Kuwahara, T., Dichosa, A. E. K., Good, C. E., Jacobs, M. R., Khoretonenko, M., Veloo, A., & Rodriguez- Palacios, A. (2021). Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health. Gut Microbes, 13(1), [1922241]. https://doi.org/10.1080/19490976.2021.1922241 Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment.
    [Show full text]
  • The Clinical Link Between Human Intestinal Microbiota and Systemic Cancer Therapy
    International Journal of Molecular Sciences Review The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy 1,2, , 1,2, 3,4 2,4 Romy Aarnoutse * y, Janine Ziemons y, John Penders , Sander S. Rensen , Judith de Vos-Geelen 1,5 and Marjolein L. Smidt 1,2 1 GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, 6229 ER Maastricht, The Netherlands 2 Department of Surgery, Maastricht University Medical Center+, 6202 AZ Maastricht, The Netherlands 3 Department of Medical Microbiology, Maastricht University Medical Center+, 6202 AZ Maastricht, The Netherlands 4 NUTRIM - School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, 6229 ER Maastricht, The Netherlands 5 Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center+, 6202 AZ Maastricht, The Netherlands * Correspondence: [email protected] or [email protected]; Tel.: +31-(0)6-82019105 These authors contributed equally to this work. y Received: 31 July 2019; Accepted: 22 August 2019; Published: 25 August 2019 Abstract: Clinical interest in the human intestinal microbiota has increased considerably. However, an overview of clinical studies investigating the link between the human intestinal microbiota and systemic cancer therapy is lacking. This systematic review summarizes all clinical studies describing the association between baseline intestinal microbiota and systemic cancer therapy outcome as well as therapy-related changes in intestinal microbiota composition. A systematic literature search was performed and provided 23 articles. There were strong indications for a close association between the intestinal microbiota and outcome of immunotherapy. Furthermore, the development of chemotherapy-induced infectious complications seemed to be associated with the baseline microbiota profile.
    [Show full text]
  • This Is a Pre-Copyedited, Author-Produced Version of an Article Accepted for Publication, Following Peer Review
    This is a pre-copyedited, author-produced version of an article accepted for publication, following peer review. Spang, A.; Stairs, C.W.; Dombrowski, N.; Eme, E.; Lombard, J.; Caceres, E.F.; Greening, C.; Baker, B.J. & Ettema, T.J.G. (2019). Proposal of the reverse flow model for the origin of the eukaryotic cell based on comparative analyses of Asgard archaeal metabolism. Nature Microbiology, 4, 1138–1148 Published version: https://dx.doi.org/10.1038/s41564-019-0406-9 Link NIOZ Repository: http://www.vliz.be/nl/imis?module=ref&refid=310089 [Article begins on next page] The NIOZ Repository gives free access to the digital collection of the work of the Royal Netherlands Institute for Sea Research. This archive is managed according to the principles of the Open Access Movement, and the Open Archive Initiative. Each publication should be cited to its original source - please use the reference as presented. When using parts of, or whole publications in your own work, permission from the author(s) or copyright holder(s) is always needed. 1 Article to Nature Microbiology 2 3 Proposal of the reverse flow model for the origin of the eukaryotic cell based on 4 comparative analysis of Asgard archaeal metabolism 5 6 Anja Spang1,2,*, Courtney W. Stairs1, Nina Dombrowski2,3, Laura Eme1, Jonathan Lombard1, Eva Fernández 7 Cáceres1, Chris Greening4, Brett J. Baker3 and Thijs J.G. Ettema1,5* 8 9 1 Department of Cell- and Molecular Biology, Science for Life Laboratory, Uppsala University, SE-75123, 10 Uppsala, Sweden 11 2 NIOZ, Royal Netherlands Institute for Sea Research, Department of Marine Microbiology and 12 Biogeochemistry, and Utrecht University, P.O.
    [Show full text]
  • Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis
    Journal of Clinical Medicine Article Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis Kei Nomura 1 , Dai Ishikawa 1,2,* , Koki Okahara 1, Shoko Ito 1, Keiichi Haga 1, Masahito Takahashi 1, Atsushi Arakawa 3, Tomoyoshi Shibuya 1 , Taro Osada 1, Kyoko Kuwahara-Arai 4, Teruo Kirikae 4 and Akihito Nagahara 1,2 1 Department of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; [email protected] (K.N.); [email protected] (K.O.); [email protected] (S.I.); [email protected] (K.H.); [email protected] (M.T.); [email protected] (T.S.); [email protected] (T.O.); [email protected] (A.N.) 2 Department of Intestinal Microbiota Therapy, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan 3 Department of Human Pathology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; [email protected] 4 Department of Microbiology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; [email protected] (K.K.-A.); [email protected] (T.K.) * Correspondence: [email protected]; Tel.: +81-(0)3-5802-1060 Abstract: Fecal microbiota transplantation following triple-antibiotic therapy (amoxicillin/fosfomycin/ metronidazole) improves dysbiosis caused by reduced Bacteroidetes diversity in patients with ulcer- ative colitis (UC). We investigated the correlation between Bacteroidetes species abundance and UC activity. Fecal samples from 34 healthy controls and 52 patients with active UC (Lichtiger’s clinical activity index ≥5 or Mayo endoscopic subscore ≥1) were subjected to next-generation sequencing Citation: Nomura, K.; Ishikawa, D.; Okahara, K.; Ito, S.; Haga, K.; with HSP60 as a target in bacterial metagenome analysis.
    [Show full text]
  • Identifying Clostridioides Difficile-Inhibiting Gut Commensals Using Culturomics, Phenotyping, and Combinatorial Community Assembly
    bioRxiv preprint doi: https://doi.org/10.1101/767715; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Identifying Clostridioides difficile-inhibiting gut commensals using culturomics, phenotyping, and combinatorial community assembly Sudeep Ghimire a, b, Chayan Roy a, b, Supapit Wongkunaa,b, Linto Antony a, b, Gavin Fenske a, b, Abhijit Maji a, b, Mitchel Chan Keena a, Andrew Foley a, and Joy Scaria a, b* aDepartment of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD, USA. bSouth Dakota Center for Biologics Research and Commercialization, SD, USA. Running Title: Human gut microbiota library conferring colonization resistance. *Address correspondence to: Joy Scaria Email: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/767715; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. ABSTRACT A major function of the gut microbiota is to provide colonization resistance, wherein pathogens are inhibited or suppressed below infectious level. However, the fraction of gut microbiota required for colonization resistance remains unclear. We used culturomics to isolate a gut microbiota culture collection comprising 1590 isolates belonging to 102 species. Estimated by metagenomic sequencing of fecal samples used for culture, this culture collection represents 50.73% of taxonomic diversity and 70% functional capacity.
    [Show full text]
  • 1,520 Reference Genomes from Cultivated Human Gut Bacteria Enable Functional Microbiome Analyses
    RESOURCE https://doi.org/10.1038/s41587-018-0008-8 1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses Yuanqiang Zou 1,2,3,13, Wenbin Xue1,2,13, Guangwen Luo1,2,4,13, Ziqing Deng 1,2,13, Panpan Qin 1,2,5,13, Ruijin Guo1,2, Haipeng Sun1,2, Yan Xia1,2,5, Suisha Liang1,2,6, Ying Dai1,2, Daiwei Wan1,2, Rongrong Jiang1,2, Lili Su1,2, Qiang Feng1,2, Zhuye Jie1,2, Tongkun Guo1,2, Zhongkui Xia1,2, Chuan Liu1,2,6, Jinghong Yu1,2, Yuxiang Lin1,2, Shanmei Tang1,2, Guicheng Huo4, Xun Xu1,2, Yong Hou 1,2, Xin Liu 1,2,7, Jian Wang1,8, Huanming Yang1,8, Karsten Kristiansen 1,2,3,9, Junhua Li 1,2,10*, Huijue Jia 1,2,11* and Liang Xiao 1,2,6,9,12* Reference genomes are essential for metagenomic analyses and functional characterization of the human gut microbiota. We present the Culturable Genome Reference (CGR), a collection of 1,520 nonredundant, high-quality draft genomes generated from >6,000 bacteria cultivated from fecal samples of healthy humans. Of the 1,520 genomes, which were chosen to cover all major bacterial phyla and genera in the human gut, 264 are not represented in existing reference genome catalogs. We show that this increase in the number of reference bacterial genomes improves the rate of mapping metagenomic sequencing reads from 50% to >70%, enabling higher-resolution descriptions of the human gut microbiome. We use the CGR genomes to annotate functions of 338 bacterial species, showing the utility of this resource for functional studies.
    [Show full text]
  • Antibiotics-Induced Monodominance of a Novel Gut Bacterial Order
    Gut microbiota ORIGINAL ARTICLE Antibiotics-induced monodominance of a novel gut Gut: first published as 10.1136/gutjnl-2018-317715 on 18 January 2019. Downloaded from bacterial order Falk Hildebrand,1 Lucas Moitinho-Silva,1 Sonja Blasche,1 Martin T Jahn,2 Toni Ingolf Gossmann,3 Jaime Huerta-Cepas,1,4 Rajna Hercog,5 Mechthild Luetge,1 Mohammad Bahram,6,7 Anna Pryszlak,1 Renato J Alves,1,8 Sebastian M Waszak,9 Ana Zhu,1,10 Lumeng Ye,11 Paul Igor Costea,1 Steven Aalvink,12 Clara Belzer,12 Sofia K Forslund,1,13 Shinichi Sunagawa,1,14 Ute Hentschel,2 Christoph Merten,1 Kiran Raosaheb Patil,1 Vladimir Benes,1 Peer Bork1,15,16 ► Additional material is ABSTRact published online only. To view Objective The composition of the healthy human Significance of the study please visit the journal online adult gut microbiome is relatively stable over prolonged (http:// dx. doi. org/ 10. 1136/ What is already known on the subject? gutjnl- 2018- 317715). periods, and representatives of the most highly abundant and prevalent species have been cultured and ► Antibiotic treatments are known to reduce For numbered affiliations see bacterial diversity short term, recovering usually end of article. described. However, microbial abundances can change on perturbations, such as antibiotics intake, enabling within weeks. ► Antibiotic-associated diarrhoea can be Correspondence to the identification and characterisation of otherwise low Professor Peer Bork, Structural abundant species. associated to blooms of pathogenic bacteria, and Computational Biology Design Analysing gut microbial time-series data, like Clostridium difficile, although the cause is Unit, European Molecular we used shotgun metagenomics to create strain level often also unknown.
    [Show full text]
  • Supplementary Table 8 Spearman's Correlations Between Targeted Urinary Urolithins and Microbiota
    Supplementary material Gut Supplementary Table 8 Spearman's correlations between targeted urinary urolithins and microbiota. Urolithin- Urolithin- Urolithin- Total A- B- C- Urolithins Family level Taxonomy glucuronid glucuronid glucuronid (A+B+C) e e e Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Bifidobacterium adolescentis_msp_0263 -0.18 -0.09 -0.16 -0.18 Bifidobacteriaceae Bifidobacterium; Bifidobacterium adolescentis Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Bifidobacterium bifidum_msp_0419 -0.12 -0.2 -0.08 -0.13 Bifidobacteriaceae Bifidobacterium; Bifidobacterium bifidum Actinobacteria; Coriobacteriia; Coriobacteriales; Coriobacteriaceae; Collinsella; Collinsella aerofaciens_msp_1244 -0.15 -0.06 -0.04 -0.18 Coriobacteriaceae Collinsella aerofaciens Actinobacteria; Coriobacteriia; Eggerthellales; Eggerthellaceae; Adlercreutzia; unclassified Adlercreutzia_msp_0396 0.09 0.01 0.16 0.12 Eggerthellaceae unclassified Adlercreutzia Actinobacteria; Coriobacteriia; Eggerthellales; Eggerthellaceae; Eggerthella; Eggerthella lenta_msp_0573 0.03 -0.15 0.08 0.03 Eggerthellaceae Eggerthella lenta Actinobacteria; Coriobacteriia; Eggerthellales; Eggerthellaceae; Gordonibacter; Gordonibacter urolithinfaciens_msp_1339 0.19 -0.05 0.18 0.19 Eggerthellaceae Gordonibacter urolithinfaciens Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae; Bacteroides; Bacteroides cellulosilyticus_msp_0003 0.12 0.11 0.15 0.15 Bacteroidaceae Bacteroides cellulosilyticus Bacteroidetes; Bacteroidia; Bacteroidales;
    [Show full text]